Lamotrigine is used in the management of seizures and bipolar disorder. Cutaneous adverse drug reactions (CADRs) including severe forms are not uncommon following lamotrigine. Existing data suggest that the risk for adverse events could be reduced by initiating the drug at a lower dose and going for a slow titration to therapeutic dose. Here, we report four cases of lamotrigine-induced CADR. Three of the four suffered from severe drug reactions and in none of them lamotrigine was administered according to recommended guidelines.